Locations

Clinical Studies

Metabolic Liver Disease

Metabolic liver disease, specifically Metabolic dysfunction-associated steatohepatitis (MASH), is a growing concern affecting a significant portion of the population. This condition causes excess fat buildup in the liver, leading to inflammation and potential scarring. While lifestyle changes are crucial, there's currently no approved medication for MASH.

Clinical trials offer a promising path to effective MASH treatments. Participating in a study allows you to contribute directly to this progress. We'd love to partner with you.

Get More Information

Your contact information

This field is for validation purposes and should be left unchanged.

Types of Studies

What studies are available?

Here you’ll find the clinical trials that we’re currently enrolling patients in or will be soon.

View All Open Studies

MASH Study
This study is for people with a diagnosis of metabolic dysfunction-associated steatohepatitis (MASH), which is a condition that causes liver inflammation and damage due to a buildup of fat in the liver. The investigational drug is being developed as a possible treatment for MASH.

Our Promise to You

What resources do you have for me?

We regularly share insights, tips, and new discoveries to provide you the latest on the diseases and chronic conditions you’re living with.

See all resources

Everything You Wanted to Know About Clinical Trials and Studies
Clinical trials are research studies that allow scientists to evaluate treatments while research studies can evaluate lifestyle interventions for Alzheimer’s and dementia. By participating, you...
Participating in a Clinical Trial — What’s It Like?
Norma Hoehndorf and her husband Wilhelm first learned about the clinical trials being conducted by Charter Research from their local newspaper, The Villages Daily Sun....